Cargando…
Circular RNAs in acute myeloid leukemia
Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While...
Autores principales: | Singh, Vijendra, Uddin, Mohammed Hafiz, Zonder, Jeffrey A., Azmi, Asfar S., Balasubramanian, Suresh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600814/ https://www.ncbi.nlm.nih.gov/pubmed/34794438 http://dx.doi.org/10.1186/s12943-021-01446-z |
Ejemplares similares
-
Exportin 1 inhibition as antiviral therapy
por: Uddin, Md. Hafiz, et al.
Publicado: (2020) -
Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia
por: Yeh, Shih-Chia, et al.
Publicado: (2023) -
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021) -
Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Dostalova Merkerova, Michaela, et al.
Publicado: (2020) -
Functions and clinical significance of circular RNAs in acute myeloid leukemia
por: Zhou, Min, et al.
Publicado: (2022)